Continuum Advisory, LLC Becton Dickinson & CO Transaction History

Continuum Advisory, LLC

  • $760 Million
  • Q4 2024

A detailed history of Continuum Advisory, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,711 shares of BDX stock, worth $383,537. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,711
Previous 1,270 34.72%
Holding current value
$383,537
Previous $306,000 26.8%
% of portfolio
0.05%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$220.02 - $243.75 $97,028 - $107,493
441 Added 34.72%
1,711 $388,000
Q3 2024

Nov 15, 2024
BUY
$221.47 - $242.41 $238,744 - $261,317
1,078 Added 561.46%
1,270 $306,000
Q2 2024

Jul 19, 2024
BUY
$225.07 - $246.17 $1,800 - $1,969
8 Added 4.35%
192 $44,000
Q1 2024

May 10, 2024
SELL
$233.45 - $247.73 $608,370 - $645,584
-2,606 Reduced 93.41%
184 $45,000
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $935,230 - $1.08 Million
-4,027 Reduced 59.07%
2,790 $680,000
Q3 2023

Nov 13, 2023
BUY
$254.9 - $283.59 $91,509 - $101,808
359 Added 5.56%
6,817 $1.76 Million
Q2 2023

Dec 13, 2023
BUY
$238.39 - $265.32 $27,176 - $30,246
114 Added 1.8%
6,458 $1.7 Million
Q2 2023

Aug 10, 2023
BUY
$238.39 - $265.32 $27,176 - $30,246
114 Added 1.8%
6,458 $1.7 Million
Q1 2023

Dec 13, 2023
SELL
$229.71 - $259.35 $4,594 - $5,187
-20 Reduced 0.31%
6,344 $1.57 Million
Q1 2023

May 12, 2023
SELL
$229.71 - $259.35 $4,594 - $5,187
-20 Reduced 0.31%
6,344 $1.57 Million
Q4 2022

Dec 13, 2023
BUY
$218.29 - $256.91 $288,579 - $339,635
1,322 Added 26.22%
6,364 $1.62 Million
Q4 2022

Feb 10, 2023
BUY
$218.29 - $256.91 $288,579 - $339,635
1,322 Added 26.22%
6,364 $1.62 Million
Q3 2022

Dec 13, 2023
BUY
$51.03 - $264.23 $5,051 - $26,158
99 Added 2.0%
5,042 $1.12 Million
Q3 2022

Nov 08, 2022
BUY
$51.03 - $264.23 $5,051 - $26,158
99 Added 2.0%
5,042 $1.12 Million
Q2 2022

Dec 13, 2023
BUY
$234.74 - $275.42 $489,667 - $574,526
2,086 Added 73.01%
4,943 $1.22 Million
Q2 2022

Aug 15, 2022
BUY
$234.74 - $275.42 $489,667 - $574,526
2,086 Added 73.01%
4,943 $1.22 Million
Q1 2022

Dec 13, 2023
SELL
$243.64 - $270.48 $964,814 - $1.07 Million
-3,960 Reduced 58.09%
2,857 $741,000
Q1 2022

May 17, 2022
BUY
$243.64 - $270.48 $696,079 - $772,761
2,857 New
2,857 $706,000
Q1 2020

May 18, 2021
SELL
$195.69 - $279.01 $175,729 - $250,550
-898 Closed
0 $0
Q4 2019

May 17, 2021
SELL
$236.45 - $266.82 $37,832 - $42,691
-160 Reduced 15.12%
898 $244,000
Q3 2019

May 18, 2021
BUY
$230.58 - $256.08 $48,421 - $53,776
210 Added 24.76%
1,058 $265,000
Q2 2019

May 18, 2021
BUY
$217.4 - $246.08 $184,355 - $208,675
848 New
848 $216,000

Others Institutions Holding BDX

# of Institutions
1,802
Shares Held
260M
Call Options Held
1.27M
Put Options Held
1.09M
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email